Data from Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [<sup>18</sup>F]AlF-FAPI-74

Abstract

<div>AbstractPurpose:<p>Despite the success of chimeric antigen receptor (CAR) T-cell therapy against hematologic malignancies, successful targeting of solid tumors with CAR T cells has been limited by a lack of durable responses and reports of toxicities. Our understanding of the limited therapeutic efficacy in solid tumors could be improved with quantitative tools that allow characterization of CAR T–targeted antigens in tumors and accurate monitoring of response.</p>Experimental Design:<p>We used a radiolabeled FAP inhibitor (FAPI) [<sup>18</sup>F]AlF-FAPI-74 probe to complement ongoing efforts to develop and optimize FAP CAR T cells. The selectivity of the radiotracer for FAP was characterized <i>in vitro</i>, and its ability to monitor changes in FAP expression was evaluated using rodent models of lung cancer.</p>Results:<p>[<sup>18</sup>F]AlF-FAPI-74 showed selective retention in FAP<sup>+</sup> cells <i>in vitro</i>, with effective blocking of the uptake in presence of unlabeled FAPI. <i>In vivo</i>, [<sup>18</sup>F]AlF-FAPI-74 was able to detect FAP expression on tumor cells as well as FAP<sup>+</sup> stromal cells in the tumor microenvironment with a high target-to-background ratio. We further demonstrated the utility of the tracer to monitor changes in FAP expression following FAP CAR T-cell therapy, and the PET imaging findings showed a robust correlation with <i>ex vivo</i> analyses.</p>Conclusions:<p>This noninvasive imaging approach to interrogate the tumor microenvironment represents an innovative pairing of a diagnostic PET probe with solid tumor CAR T-cell therapy and has the potential to serve as a predictive and pharmacodynamic response biomarker for FAP as well as other stroma-targeted therapies. A PET imaging approach targeting FAP expressed on activated fibroblasts of the tumor stroma has the potential to predict and monitor therapeutic response to FAP-targeted CAR T-cell therapy.</p><p><i><a href="https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-22-2565" target="_blank">See related commentary by Weber et al., p. 5241</a></i></p></div>